PD49-01 SECONDARY POLYCYTHEMIA WHILE ON TESTOSTERONE THERAPY INCREASES RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND VENOUS THROMBOEMBOLISM IN MEN: INSIGHTS FROM A GLOBAL HEALTH RESEARCH NETWORK. (May 2022)